Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Learn which type of credit card—cash back or points—provides more benefits based on your spending habits and preferences.
28,383 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
In March 2026, smart japan investors choosing hedged exposure via DXJ are gaining ground as currency moves and reform...
Visa unveils a new internal platform to extend stablecoin services across its vast payment network, aiming to slash c...
After-hours moves often reveal the next chapter for crypto firms. Gemini shares rise after hours as investors embrace...
Want crypto exposure without sacrificing diversification? This guide shows how crypto etfs part diversified fits into...
Airbnb posts a solid Q4, prompting Truist to lift its target to $129 and move the stock to Hold. The shift signals a ...
As major indices retreat in March, traders question whether Trump losing grip market? influence is waning. Volatility...
A private Dallas developer secures a government-backed funding package to build a Gulf of Mexico deepwater oil termin...
Eli Lilly's ascent to the top of the drug charts centers on a single family of medicines. This article breaks down wh...
Are you weighing a Roth IRA conversion? This guide highlights three signals that 2026 could perfect your move, plus a...
As negotiators in Beijing steer talks between the U.S. and China, investors are eyeing three names likely to move: NV...
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...